GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

Home・Akciju saraksts・Vitrolife AB

V
Vitrolife AB

Slēgts

138.6 0.36

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

134.7

Max

139.2

Galvenie mērījumi
By Trading Economics
Ienākumi	-30M 102M
Pārdošana	-36M 835M
P/E Sektora vidējais	42.154 77.671
EPS	0.753
Dividenžu ienesīgums	0.78
Peļņas marža	12.216
Darbinieki	1,100
EBITDA	118M 255M

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	0.78% 2.35%
Nākamie ieņēmumi	2026. g. 3. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-1.3B 19B
Iepriekšējā atvēršanas cena	138.24
Iepriekšējā slēgšanas cena	138.6

Vitrolife AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 11. dec. 23:58 UTC

Iegādes, apvienošanās, pārņemšana

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

2025. g. 11. dec. 23:56 UTC

Peļņas

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

2025. g. 11. dec. 23:03 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

2025. g. 11. dec. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

2025. g. 11. dec. 21:50 UTC

Peļņas

Costco Same-Store Sales, Membership Fees Rose in 1Q

2025. g. 11. dec. 23:45 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 11. dec. 23:44 UTC

Tirgus saruna

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

2025. g. 11. dec. 23:37 UTC

Tirgus saruna

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

2025. g. 11. dec. 23:31 UTC

Peļņas

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025. g. 11. dec. 22:48 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

2025. g. 11. dec. 22:35 UTC

Peļņas

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

2025. g. 11. dec. 22:30 UTC

Peļņas

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

2025. g. 11. dec. 22:09 UTC

Iegādes, apvienošanās, pārņemšana

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

2025. g. 11. dec. 22:06 UTC

Iegādes, apvienošanās, pārņemšana

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

2025. g. 11. dec. 22:05 UTC

Peļņas

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025. g. 11. dec. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

2025. g. 11. dec. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 11. dec. 21:39 UTC

Peļņas

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

2025. g. 11. dec. 21:39 UTC

Peļņas

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

2025. g. 11. dec. 21:38 UTC

Peļņas

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

2025. g. 11. dec. 21:37 UTC

Peļņas

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

2025. g. 11. dec. 21:37 UTC

Tirgus saruna

Broadcom Sees AI Revenue Doubling -- Market Talk

2025. g. 11. dec. 21:34 UTC

Iegādes, apvienošanās, pārņemšana

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

2025. g. 11. dec. 21:29 UTC

Iegādes, apvienošanās, pārņemšana

Dexus Aiming for Long-Term Holding of A$50M in Fund

2025. g. 11. dec. 21:28 UTC

Tirgus saruna

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

2025. g. 11. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Dexus Expects to Introduce Additional Third-Party Equity in FY26

2025. g. 11. dec. 21:28 UTC

Iegādes, apvienošanās, pārņemšana

Dexus: Third Party Investors to Contribute Remainder

2025. g. 11. dec. 21:27 UTC

Iegādes, apvienošanās, pārņemšana

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

2025. g. 11. dec. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

2025. g. 11. dec. 21:25 UTC

Iegādes, apvienošanās, pārņemšana

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Salīdzinājums

Cenas izmaiņa

Vitrolife AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.